Defilade Capital Management, L.P. 13F holdings
Defilade Capital Management, L.P. reported 39 positions with a total reported value of $746.9M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: LLY ELI LILLY & CO (6.3%), PFE PFIZER INC (5.7%), VEEV VEEVA SYS INC (5.6%), BMRN BIOMARIN PHARMACEUTICAL INC (5.2%), PTCT PTC THERAPEUTICS INC (4.7%). Against 2026-03-31 it opened 19 new positions and exited 11. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Defilade Capital Management, L.P. files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 39 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| LLY ELI LILLY & CO | 39,086 | $46.9M | 6.3% |
| PFE PFIZER INC | 1,771,743 | $42.7M | 5.7% |
| VEEV VEEVA SYS INC | 236,709 | $42.0M | 5.6% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 682,005 | $39.0M | 5.2% |
| PTCT PTC THERAPEUTICS INC | 433,699 | $35.4M | 4.7% |
| BAXTER INTL INC | 1,459,380 | $31.1M | 4.2% |
| INSM INSMED INC | 281,838 | $30.0M | 4.0% |
| ZBH ZIMMER BIOMET HOLDINGS INC | 317,426 | $27.3M | 3.7% |
| PODD INSULET CORP | 176,932 | $26.9M | 3.6% |
| TMO THERMO FISHER SCIENTIFIC INC | 51,934 | $26.0M | 3.5% |
| ABT ABBOTT LABORATORIES | 285,778 | $25.9M | 3.5% |
| ASND ASCENDIS PHARMA A/S | 94,843 | $25.3M | 3.4% |
| SOLV SOLVENTUM CORP | 316,454 | $24.4M | 3.3% |
| MDT MEDTRONIC PLC | 303,301 | $23.7M | 3.2% |
| ELAN ELANCO ANIMAL HEALTH INC | 864,080 | $21.3M | 2.8% |
| AGIO AGIOS PHARMACEUTICALS INC | 546,848 | $20.3M | 2.7% |
| NVST ENVISTA HOLDINGS CORPORATION | 726,108 | $19.1M | 2.6% |
| RVMD REVOLUTION MEDICINES INC | 82,827 | $15.5M | 2.1% |
| ICUI ICU MED INC | 105,700 | $15.5M | 2.1% |
| COGT COGENT BIOSCIENCES INC | 393,441 | $15.2M | 2.0% |
| LNTH LANTHEUS HLDGS INC | 132,662 | $14.7M | 2.0% |
| OCUL OCULAR THERAPEUTIX INC | 1,490,286 | $14.6M | 2.0% |
| ELDN ELEDON PHARMACEUTICALS INC | 3,525,338 | $13.9M | 1.9% |
| TYRA TYRA BIOSCIENCES INC | 376,870 | $12.0M | 1.6% |
| OLMA OLEMA PHARMACEUTICALS INC | 924,758 | $11.6M | 1.5% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 19 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| VEEV VEEVA SYS INC | 236,709 | $42.0M | 5.6% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 682,005 | $39.0M | 5.2% |
| BAXTER INTL INC | 1,459,380 | $31.1M | 4.2% |
| PODD INSULET CORP | 176,932 | $26.9M | 3.6% |
| TMO THERMO FISHER SCIENTIFIC INC | 51,934 | $26.0M | 3.5% |
| ABT ABBOTT LABORATORIES | 285,778 | $25.9M | 3.5% |
| SOLV SOLVENTUM CORP | 316,454 | $24.4M | 3.3% |
| MDT MEDTRONIC PLC | 303,301 | $23.7M | 3.2% |
| AGIO AGIOS PHARMACEUTICALS INC | 546,848 | $20.3M | 2.7% |
| NVST ENVISTA HOLDINGS CORPORATION | 726,108 | $19.1M | 2.6% |
| TYRA TYRA BIOSCIENCES INC | 376,870 | $12.0M | 1.6% |
| LRMR LARIMAR THERAPEUTICS INC | 3,670,135 | $11.2M | 1.5% |
| ENOV ENOVIS CORPORATION | 531,945 | $11.0M | 1.5% |
| TFX TELEFLEX INCORPORATED | 80,118 | $10.2M | 1.4% |
| GKOS GLAUKOS CORP | 66,519 | $9.3M | 1.2% |
| STAA STAAR SURGICAL CO | 322,126 | $9.2M | 1.2% |
| CRNX CRINETICS PHARMACEUTICALS IN | 239,440 | $9.0M | 1.2% |
| LIVN LIVANOVA PLC | 107,373 | $8.8M | 1.2% |
| BDTX BLACK DIAMOND THERAPEUTICS I | 1,674,999 | $3.1M | 0.4% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 11 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| HSIC SCHEIN HENRY INC | 1,248,074 | $92.0M | 6.5% |
| BDX BECTON DICKINSON & CO | 558,420 | $87.8M | 6.2% |
| DXCM DEXCOM INC | 1,077,524 | $67.7M | 4.8% |
| ISRG INTUITIVE SURGICAL INC | 135,362 | $62.4M | 4.4% |
| NBIX NEUROCRINE BIOSCIENCES INC | 419,864 | $55.3M | 3.9% |
| ITGR INTEGER HLDGS CORP | 426,054 | $37.5M | 2.6% |
| BIIB BIOGEN INC | 192,578 | $35.3M | 2.5% |
| TNDM TANDEM DIABETES CARE INC | 1,523,810 | $29.2M | 2.1% |
| NUVL NUVALENT INC | 259,900 | $26.6M | 1.9% |
| ALGN ALIGN TECHNOLOGY INC | 134,664 | $23.1M | 1.6% |
| BHVN BIOHAVEN LTD | 631,888 | $5.3M | 0.4% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| RVMD REVOLUTION MEDICINES INC | 631,944 | 82,827 | -86.9% | $15.5M |
| ZBH ZIMMER BIOMET HOLDINGS INC | 1,158,322 | 317,426 | -72.6% | $27.3M |
| DNLI DENALI THERAPEUTICS INC | 2,719,938 | 391,866 | -85.6% | $10.1M |
| ICUI ICU MED INC | 508,582 | 105,700 | -79.2% | $15.5M |
| GMED GLOBUS MED INC | 708,700 | 139,637 | -80.3% | $11.0M |
| PACS PACS GROUP INC | 1,208,360 | 215,675 | -82.2% | $9.2M |
| LNTH LANTHEUS HLDGS INC | 498,802 | 132,662 | -73.4% | $14.7M |
| PFE PFIZER INC | 2,928,258 | 1,771,743 | -39.5% | $42.7M |
| OLMA OLEMA PHARMACEUTICALS INC | 3,009,072 | 924,758 | -69.3% | $11.6M |
| PTCT PTC THERAPEUTICS INC | 752,330 | 433,699 | -42.4% | $35.4M |
| ELAN ELANCO ANIMAL HEALTH INC | 1,862,242 | 864,080 | -53.6% | $21.3M |
| OCUL OCULAR THERAPEUTIX INC | 2,975,290 | 1,490,286 | -49.9% | $14.6M |
CIK 2088557 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
